Tata Chemicals Limited · NSE:TATACHEM
Tata Chemicals — Q4 FY2019 Earnings Presentation
17 slides from Tata Chemicals's earnings presentation, May 3, 2019
Slide 1: Submission of Analysts/Investors Presentation to exchanges
qt ^-. TATA May 3, 2019 The Secretary, Listing Department The Manager, Listing Department BSE Limited National Stock Exchange of lndia Ltd Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/l Dalal Street G Block, Bandra-Kurla Complex Mumbai 400 001 Bandra (E) Scrip Code: 500770 Mumbai
Slide 2: Investors & Analyst Communication on Financial Results Q4 & year ended 31 March 2019
Investors & Analyst Communication on Financial Results Q4 & year ended 31 March 2019 Dated: : 3 May 2019 1
Slide 3: Safe Harbour Statement
Safe Harbour Statement “This Presentation, except for the historical information, may contain statements, including the words or phrases such as ‘expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should’ and similar expression
Slide 4: Key Highlights
Key Highlights • Highest sales volumes of Tata Salt • Highest ever Operating Profit • Consummated ₋ Sale of Phosphatic Fertiliser Business in June 2018 ₋ Acquisition of Silica Business in June 2018 • Operating Working Capital at Standalone is all time low Q4 FY19 Continuing Operations: • Revenues :
Slide 5: Financial Performance: Q4 Mar FY2019
Financial Performance: 3 months ended Mar19 (Q4 Mar - FY2019) Continuing Operations Only 19% 16% 20% 531 450 512 14% 356 Consolidated 2,759 2,555 Q4 Mar 18 Q4 Mar 19 Q4 Mar 18 Q4 Mar 19 Q4 Mar 18 Q4 Mar 19 Revenue EBITDA PAT 22% 25% 28% 266 230 257 19% 175 Standalone 1,059 918 Q4 Mar 18 Q4 Mar 19 Q4
Slide 6: Financial Performance: YTD Mar FY2019
Financial Performance: 12 months ended Mar19 (YTD Mar - FY2019) Continuing Operations Only 21% 15% 19% 12% 2,191 1,560 2,095 1,395 Consolidated 11,296 10,345 YTD Mar 18 YTD Mar 19 YTD Mar 18 YTD Mar 19 YTD Mar 18 YTD Mar 19 Revenue EBITDA PAT 22% 25% 26% 918 1,002 922 18% Standalone 624 4,081 3,524
Slide 7: Financial Performance: Segment Information (Q4 Mar - FY2019)
Financial Performance: Segment Information (Q4 Mar - FY2019) Consolidated Standalone *Excludes Inter Segment Revenue of Rs 284 Cr (PY Rs. 186 Cr) & *Excludes Inter Segment Revenue of Rs 281 Cr (PY Rs. 184 Cr) & Unallocated Revenue of Rs 3 Cr (PY Rs 4 Cr) Unallocated Revenue of Rs 1 Cr (PY Rs 4 Cr) Q
Slide 8: Financial Position: Balance Sheet
Financial Position: Balance Sheet Consolidated Standalone Rs Cr 31-Mar-18 31-Mar-19 31-Mar-18 31-Mar-19 ASSETS Non - Current Assets 16,839 18,807 8,484 9,528 Current Assets Inventories 1,462 1,726 451 628 Trade Receivables 1,308 1,453 140 185 Cash and Cash Equivalent* 4,575 4,204 3,769 3,247 Others
Slide 9: Financial Update: Borrowing position
Financial Update: Borrowing position Debt Waterfall chart – Consolidated 614 339 4,184 6,418 6,143 1,959 Gross Debt Mar'18 Net Change Revaluation Gross Debt Mar'19 Cash & Cash Net Debt Equivalents Debt Waterfall chart – Standalone 777 3,229 1,407 708 78 2,521 Gross Debt Mar'18 Net Change Revaluation
Slide 10: Business Updates: Basic Chemistry Products
Business Updates: Basic Chemistry Products Q4 Segment Revenue & Results • India business continues to perform as per expectation. Revenues stood Segment Revenue Segment Results at Rs 853 Cr (up 25% vs PY), due to higher sales volumes in soda ash and Sodium bicarbonate and better sales realization, w
Slide 11: Business Updates: Consumer Products
Business Updates: Consumer Products Q4 Segment Revenue & Results • Salt Business continues to maintain its leadership position, with more Segment Revenue Segment Results than 25% market share in edible salt market and approximately 65% market share in branded salt market. • Revenues from Pulses and
Slide 12: Business Updates: Specialty Products
Business Updates: Specialty Products Q4 Segment Revenue & Results • Under Specialty products, Nutritional solutions business had a Segment Revenue Segment Results challenging quarter, as revenue where marginally impacted due to lower sales volumes. Margins where also impacted due to higher fixed cos
Slide 13: Business Updates: Subsidiary Financials
Business Updates: Subsidiary Financials Q4 Mar – FY2019 Units TCL India US UK Africa Rallis Consolidated* Rs Cr PY CY PY CY PY CY PY CY PY CY PY CY Revenue 918 1,059 819 870 368 381 136 141 371 340 2,555 2,759 EBITDA 257 266 141 205 79 27 21 31 35 7 512 531 PBT 271 283 68 234 28 (30) 11 23 25 6 372
Slide 14: Key Products: Production & Sales
Key Products: Production & Sales Soda Ash Quantity (In Kts.) Sodium Bicarbonate Quantity (In Kts.) Branded Salt Quantity (In Kts) TCL India TCE TCML TCNA TCL India TCE Q4 Mar- FY2019 539 30 28 28 27 589 550 600 283 284 79 87 82 276 85 86 78 76 88 25 28 27 26 270 175 182 212 213 113 107 107 108 2,350
Slide 15: Awards, Recognitions and Customer connect
Awards, Recognitions and Customer connect Awards & Recognitions Customer Connect Utsav Exhibition, Pune (Oct’18) 14
Slide 16: Other Financials Highlights
Other Financials Highlights Trailing Quarters – Consolidated Revenue (Rs Cr) & PAT* Margin (%) Earnings Per Share (Consolidated) Revenue Margin 12.2 12.6 12.2 14% 10% 14% 10% 16% 9.7 2,961 2,832 2,744 2,759 8.4 2,555 Q4 FY18 Q1 FY19 Q2 FY19 Q3 FY19 Q4 FY19 Q4 FY18 Q1 FY19 Q2 FY19 Q3 FY19 Q4 FY19 Sha
Slide 17: Tata Chemicals – Contact
TATA CHEMICALS Transform Grow For any question/queries please contact & John Mulhall & jmulhall@tatachemicals.com & Sameer Kulkarni & sakulkarni@tatachemicals.com & Gavin Desa & gavin@cdr-india.com & Suraj Digawalekar & suraj@cdr-india.com ® +91 22 6665 8282 ® +91 22 6665 7942 ® +91 226645 1237 © +9